- Home
- BIIB vs EVRG Comparison
BIIB vs EVRG Comparison
Compare BIIB & EVRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BIIB | EVRG |
|---|---|---|
| Founded | 1978 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 17.9B |
| IPO Year | 1991 | N/A |
Fundamental Metrics
Financial Performance| Metric | BIIB | EVRG |
|---|---|---|
| Price | $181.61 | $73.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 10 |
| Target Price | ★ $176.48 | $78.35 |
| AVG Volume (30 Days) | ★ 1.9M | 1.8M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 10.97 | 3.66 |
| Revenue | ★ $10,065,900,000.00 | $5,878,800,000.00 |
| Revenue This Year | $3.61 | $4.97 |
| Revenue Next Year | N/A | $3.96 |
| P/E Ratio | ★ $16.52 | $20.04 |
| Revenue Growth | ★ 4.77 | 1.75 |
| 52 Week Low | $110.04 | $59.67 |
| 52 Week High | $185.17 | $79.32 |
Technical Indicators
Market Signals| Indicator | BIIB | EVRG |
|---|---|---|
| Relative Strength Index (RSI) | 72.92 | 34.30 |
| Support Level | $174.53 | $74.90 |
| Resistance Level | $182.94 | $77.63 |
| Average True Range (ATR) | 5.22 | 1.13 |
| MACD | 0.25 | -0.36 |
| Stochastic Oscillator | 83.54 | 2.27 |
Price Performance
Historical ComparisonAbout BIIB Biogen Inc.
Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (18% of total in 2024), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
About EVRG Evergy Inc.
Evergy is a regulated electric utility serving eastern Kansas and western Missouri. Major operating subsidiaries include Evergy Metro, Evergy Kansas Central, Evergy Missouri West, and Evergy Transmission Co. The utility has a combined rate base of approximately $20 billion, about half in Kansas and the rest split between Missouri and federal jurisdiction. Evergy is one of the largest wind energy suppliers in the US.